Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00853073 · ClinicalTrials.gov registry record · Phase 2
Does Adding Bevacizumab Therapy in Glaucoma Surgery Improve the Success of Needle Bleb Revisions?
A Phase 2 study, sponsored by Wills Eye.
- Completed
- Registry status
- Phase 2
- Development phase
- 63
- Enrollment target
NCT00853073 is a Phase 2 study that has completed, run by Wills Eye. The registered enrollment target is 63 participants.
The verdict
NCT00853073, a Phase 2 study, has completed, sponsored by Wills Eye.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 63 participants
- Enrollment target
Study Summary
The purpose of this study is to see if a new add on (or adjunctive) therapy used in glaucoma surgery improves the success of needle bleb revisions.
Interventions
- DRUG bevacizumab
- OTHER balanced salt solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2009-02 |
| Est. Completion | 2012-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00853073
The ClinicalTrials.gov registry entry for NCT00853073 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wills Eye, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which bevacizumab is the first listed.
NCT00853073 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00853073 about?
NCT00853073 is a clinical study titled "Does Adding Bevacizumab Therapy in Glaucoma Surgery Improve the Success of Needle Bleb Revisions?". The purpose of this study is to see if a new add on (or adjunctive) therapy used in glaucoma surgery improves the success of needle bleb revisions.
What is the current status of trial NCT00853073?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 63 participants. The study started on 2009-02. Estimated completion is 2012-01.
What interventions are being tested in trial NCT00853073?
The interventions under investigation include: bevacizumab (DRUG), balanced salt solution (OTHER).
Who is sponsoring clinical trial NCT00853073?
This trial is sponsored by Wills Eye, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.